NHLBI TOPMed: Whole Genome Sequencing of Venous Thromboembolism (WGS of VTE)

Request Access

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

J. Heit, Marc D. Silverstein, Marc D. Silverstein, et al.. (2000). Archives of internal medicine. Cited 2,268 times. https://doi.org/10.1001/ARCHINTE.160.6.809

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

J. Heit, D. Mohr, M. Silverstein, et al.. (2000). Archives of internal medicine. Cited 940 times. https://doi.org/10.1001/archinte.160.6.761

Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.

M. Germain, D. Chasman, H. D. de Haan, et al.. (2015). American journal of human genetics. Cited 248 times. https://doi.org/10.1016/j.ajhg.2015.01.019

A genome‐wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q

J. Heit, Sebastian M. Armasu, Y. Asmann, et al.. (2012). Journal of Thrombosis and Haemostasis. Cited 152 times. https://doi.org/10.1111/j.1538-7836.2012.04810.x

A Genome‐Wide Association Study for Venous Thromboembolism: The Extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium

Weihong Tang, M. Teichert, D. Chasman, et al.. (2013). Genetic Epidemiology. Cited 127 times. https://doi.org/10.1002/gepi.21731

The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies.

J. Dennis, Candice Y Johnson, A. Adediran, et al.. (2012). Blood. Cited 75 times. https://doi.org/10.1182/blood-2011-10-383448

Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.

J. Heit, B. Lahr, A. Ashrani, et al.. (2015). Thrombosis research. Cited 49 times. https://doi.org/10.1016/j.thromres.2015.06.030

Identifying In-Hospital Venous Thromboembolism (VTE): A Comparison of Claims-Based Approaches With the Rochester Epidemiology Project VTE Cohort

C. Leibson, J. Needleman, P. Buerhaus, et al.. (2008). Medical Care. Cited 46 times. https://doi.org/10.1097/MLR.0b013e3181589b92

Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population‐based case–control study

J. Heit, T. Petterson, W. Owen, et al.. (2005). Journal of Thrombosis and Haemostasis. Cited 42 times. https://doi.org/10.1111/j.1538-7836.2005.01187.x

Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case–control study

A. Ashrani, M. Silverstein. (2009). Vascular Medicine. Cited 28 times. https://doi.org/10.1177/1358863X09104222

Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: A nested case-control study

A. Ashrani, Marc D. Silverstein, T. Rooke, et al.. (2010). Vascular Medicine. Cited 24 times. https://doi.org/10.1177/1358863X10379672

Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

A. Ashrani, M. Barsoum, D. Crusan, et al.. (2015). Thrombosis research. Cited 22 times. https://doi.org/10.1016/j.thromres.2015.04.005

Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.

J. P. Botero, W. Ormsby, A. Ashrani, et al.. (2016). European journal of internal medicine. Cited 12 times. https://doi.org/10.1016/j.ejim.2016.02.023

Characteristics of abdominal vein thrombosis in children and adults

D. Landi, M. Beckman, N. Shah, et al.. (2013). Thrombosis and Haemostasis. Cited 6 times. https://doi.org/10.1160/TH12-08-0568
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747